avapro has been researched along with omega-n-methylarginine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allard, SE; Browne, DL; Cummings, MH; Meeking, DR; Munday, JL; Shaw, KM | 1 |
1 trial(s) available for avapro and omega-n-methylarginine
Article | Year |
---|---|
Angiotensin II does not affect endothelial tone in Type 1 diabetes-results of a double-blind placebo controlled trial.
Topics: Acetylcholine; Adult; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Cyclooxygenase Inhibitors; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Female; Forearm; Humans; Indomethacin; Infusions, Intra-Arterial; Irbesartan; Male; Nitroprusside; omega-N-Methylarginine; Regional Blood Flow; Tetrazoles; Vasoconstriction; Vasodilator Agents | 2006 |